Chief Executive Officer of SAGE Labs, Inc
Dr. David A. Smoller, Ph.D. serves as Chief Executive Officer of SAGE Labs, Inc. Dr. Smoller serves as a General Partner at Cultivation Capital Life Sciences Fund, LLC and Cultivation Capital. Dr. Smoller has been an Independent Consultant at Sigma-Aldrich Corporation since August 3, 2012. Dr. Smoller served as the Chief Scientific Officer at Sigma-Aldrich Corporation since February 2011 until August 3, 2012. Dr. Smoller served as the President of Research Biotech Business Unit at Sigma-Aldrich Corp. since July 5, 2007 and served as its Vice President of Research and Development since June 1, 2004. Dr. Smoller served as President and Chief Executive Officer at ProteoPlex, Inc. Dr. Smoller founded ProteoPlex in 2001 and led through its product development and final acquisition. In 1992, Dr. Smoller founded Genome Systems Inc., which provided the scientific community with access to genome project-related technologies. Dr. Smoller stayed at the helm of Genome Systems Inc. until it was acquired in 1996 by the Incyte Corporation. Dr. Smoller joined Incyte as Vice President eventually becoming Senior Vice President and leader of the St. Louis organization growing the staff to more than 250 people. Dr. Smoller has been a Board Member of Adarza BioSystems, Inc. since July 18, 2013. Dr. Smoller earned a Doctorate degree in Molecular Biology and a Bachelor’s degree in Biology from Emory University in Atlanta, Georgia. He completed a postdoctoral fellowship from Washington University in the Drosophila Genome project and a postdoctoral fellowship at Monsanto Corporation.